Osteofibrous Dysplasia and Adamantinoma.
2021
For decades, the diagnosis, treatment, and even pathogenesis of the osteofibrous dysplasia/osteofibrous dysplasia-like adamantinoma/classic adamantinoma spectrum of neoplasms have been controversial. Herein, we discuss and illustrate the radiographic and histologic spectrum, differential diagnoses, unifying chromosomal and molecular abnormalities, and current controversies and treatment recommendations for each entity.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
0
Citations
NaN
KQI